Q1 2021 13F Holders as of 31 Mar 2021
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
31,249,203
-
Total 13F shares
-
1,310,290
-
Share change
-
-694,983
-
Total reported value
-
$9,986,632
-
Put/Call ratio
-
2%
-
Price per share
-
$7.62
-
Number of holders
-
33
-
Value change
-
-$5,421,678
-
Number of buys
-
12
-
Number of sells
-
25
Institutional Holders of Actinium Pharmaceuticals, Inc. - Common Stock (ATNM) as of Q1 2021
As of 31 Mar 2021 Actinium Pharmaceuticals, Inc. - Common Stock (ATNM) had 33 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 1,310,290 shares of stock of the company.
Largest 10 holders included VANGUARD GROUP INC, BlackRock Inc., GEODE CAPITAL MANAGEMENT, LLC, BRIDGEWAY CAPITAL MANAGEMENT, LLC, Bank of New York Mellon Corp, SILVERARC CAPITAL MANAGEMENT, LLC, GSA CAPITAL PARTNERS LLP, FIRST TRUST ADVISORS LP, BLAIR WILLIAM & CO/IL, and NORTHERN TRUST CORP.
This table shows 33 institutional shareholders of the security as of 31 Mar 2021.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.